Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Cureus ; 14(7): e27364, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36046272

RESUMO

Objective This study was aimed at analyzing the validity and reliability of the Papanicolaou (Pap) test and visual inspection with acetic acid (VIAA) tests for cervical dysplasia screenings during the COVID-19 pandemic. Material and methods This was a retrospective study of patients 21 years or older seen at the Luis Negreiros Primary Care Center in Lima, Peru between 2020 and 2021, who underwent cervical dysplasia screening (Pap or VIAA). Relevant information regarding patient age, date of service, and Pap and VIAA results were collected. Parallel form reliability was analyzed with chi-square tests, and phi, contingency and Cramer's V coefficients. The validity of these tests was analyzed through the calculation of the sensitivity, specificity, and positive and negative predictive values with confidence intervals. A p-value less than 0.05 indicated statistical significance. Results From 4,503 records, the sensitivity, specificity, and positive and negative predictive values for Pap were 0.87 (0.81-0.92), 1.0 (1.0-1.0), 1.0 (1.0-1.0) and 0.99 (0.98-0.99), respectively, and those for VIAA were 0.22 (0.14-0.31), 0.10 (0.10-0.10), 0.53 (0.38-0.69) and 0.10 (0.10-0.10), respectively. Test validity varied slightly according to patient age and the year of testing. The correlation, although significant, was inverse; chi-square = 39.18, p <0.001, phi = -0.60, contingency = 0.51 and Cramer's V = -0.59. Conclusion The validity and reliability of Pap testing and VIAA for cervical dysplasia screening significantly decreased during the COVID-19 pandemic. The correlation between these tests, although significant, was inverse. More larger-scale studies are needed to confirm these findings and understand the reasons underlying the decreased effectiveness of these tests.

2.
Arch Gynecol Obstet ; 295(2): 375-381, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27844211

RESUMO

PURPOSE: Evaluate whether morbid obesity influenced resolution, number of doses or ultimately surgical management of tubal ectopic pregnancy (TEP) when treated with single-dose regimen methotrexate (SDR-MTX) capped at 100 mg. METHODS: Retrospective cohort study of patients with a diagnosis of TEP who underwent MTX treatment from 2000 to 2013. Patients were excluded if initial ß-hCG <1000 mIU/mL, did not have ß-hCG follow-up or were not treated with SDR-MTX. Per protocol, dose was administered at 50 mg/m2 with a capped maximum of 100 mg. Patients were divided based on their BMI (<40 and ≥40 kg/m2). Demographic variables, ß-hCG before treatment, maximum diameter of ectopic size, embryonic heart tones, decrease of ß-hCG, need for additional MTX doses and surgery despite treatment were recorded and compared among the groups. RESULTS: 151 women were included in the study, 89.4% (135/151) non-morbidly obese and 10.6% (16/151) morbidly obese. No differences in age distribution, ethnicity, pre-treatment presence of embryonic heart tones, maximum diameter of ectopic size ≥35 mm and ß-hCG ≥5000 mIU/ml were found. Following treatment, the proportion of patients with at least an 80% decrease in their ß-hCG levels or need for surgery were similar, however, morbidly obese patients were significantly more likely [11/134 vs. 5/16, OR 5.1 (1.5-17.3, p = 0.015)] to require an additional MTX dose. CONCLUSION: Among patients with TEP, morbidly obese patients were five times more likely to require an additional dose compared to non-morbidly obese when SDR-MTX capped at 100 mg was used for medical management.


Assuntos
Abortivos não Esteroides/uso terapêutico , Metotrexato/uso terapêutico , Obesidade Mórbida/complicações , Gravidez Ectópica/tratamento farmacológico , Adulto , Gonadotropina Coriônica Humana Subunidade beta/sangue , Estudos de Coortes , Feminino , Humanos , Gravidez , Gravidez Ectópica/sangue , Estudos Retrospectivos
3.
Artigo em Inglês | LILACS | ID: lil-612952

RESUMO

Objetivo. Describir el uso de antibióticos en niños de 2 a 12 meses de edad en entornos donde estos medicamentos se pueden obtener sin prescripción. Métodos. Se analizaron los datos de un estudio de cohorte efectuado entre septiembre del 2006 y diciembre del 2007 en 1 023 niños menores de 2 meses de la zonaperiurbana de Lima, Perú, cuyo seguimiento se realizó hasta el año de edad. Resultados. De los 1 023 niños, 770 (75,3%) tomaron 2 085 tandas de tratamiento antibiótico. Se registraron dos tandas por niño por año (rango 0–12). Las tasas más elevadas de uso de antibióticos se encontraron en los niños de 3 a 6 meses (37,2%). Los niños recibieron antibióticos para 8,2% de los resfriados comunes, 58,6% de las faringitis, 66,0% de las bronquitis, 40,7% de las diarreas, 22,8% de las dermatitis y 12,0% de las obstruccionesbronquiales. La prescripción de un médico fue la razón más frecuente para el uso de antibióticos (90,8%). Se comprobó el uso de medicamentos sin prescripción en 6,9% de los niños, y en 63,9% de ellos este fue precedido por una prescripción médica. Conclusiones. En el entorno estudiado, los niños menores de 1 año a menudo estánexpuestos a los antibióticos. El abuso de los antibióticos es frecuente ante enfermedades como faringitis, bronquitis, obstrucción bronquial y diarrea, pero por lo general es inadecuado (83,1% de las tandas de tratamiento antibiótico) según las etiologías más comunes en este grupo etario. Las intervenciones dirigidas a mejorar el uso de los antibióticos deben concentrarse en los médicos, ya que la prescripción médica fue la razón más común para el uso de antibióticos.


Objective. To describe the use of antibiotics in Peruvian children under 1 year in a setting where they are available without a prescription. Methods. Data were analyzed from a cohort study between September 2006 and December 2007 of 1 023 children < 2 months old in periurban Lima, Peru, followed until they were 1 year old. Results. Seven hundred seventy of 1 023 (75.3%) children took 2 085 courses of antibiotics. There were two courses per child per year (range 0–12). Higher rates of antibiotic usewere found in children 3–6 months old (37.2%). Antibiotics were given to children for 8.2% of common colds, 58.6% of all pharyngitis, 66.0% of bronchitis, 40.7% of diarrheas, 22.8%of dermatitis, and 12.0% of bronchial obstructions. A physician’s prescription was the most common reason for antibiotic use (90.8%). Medication use without a prescription was found in 6.9% of children, and in 63.9% of them it was preceded by a physician’s prescription. Conclusions. Infants are often exposed to antibiotics in this setting. Overuse of antibiotics is common for diagnoses such as pharyngitis, bronchitis, bronchial obstruction, and diarrhea but is typically inappropriate (83.1% of courses) based on the most common etiologies for this age group. Interventions to improve the use of antibiotics should focus on physicians, since a physician’s prescription was the most common reason for antibiotic use.


Assuntos
Feminino , Humanos , Lactente , Masculino , Antibacterianos/uso terapêutico , Resistência Microbiana a Medicamentos , Promoção da Saúde , Prescrição Inadequada/estatística & dados numéricos , Bem-Estar do Lactente , Padrões de Prática Médica/estatística & dados numéricos , Papel do Médico , Responsabilidade Social , Saúde Suburbana , Bronquite/tratamento farmacológico , Bronquite/epidemiologia , Estudos de Coortes , Resfriado Comum/tratamento farmacológico , Resfriado Comum/epidemiologia , Dermatite/tratamento farmacológico , Dermatite/epidemiologia , Diarreia Infantil/tratamento farmacológico , Diarreia Infantil/epidemiologia , Uso de Medicamentos/estatística & dados numéricos , Seguimentos , Peru/epidemiologia , Faringite/tratamento farmacológico , Faringite/epidemiologia , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/epidemiologia
4.
Int J Infect Dis ; 13(5): e206-11, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19233701

RESUMO

BACKGROUND: Ocular brucellosis is usually diagnosed by clinical criteria and serological tests. Little is known with regard to the ocular immunology of brucellosis and the use of intraocular diagnostic tests. We report retrospectively the laboratory findings of patients with ocular involvement associated with brucellosis. MATERIALS AND METHODS: Patients with uveitis with no evident etiologic diagnosis were evaluated at the Instituto de Medicina Tropical "Alexander von Humboldt" of the Universidad Peruana Cayetano Heredia and the Hospital Nacional Cayetano Heredia. Patients were tested for brucellosis, tuberculosis, syphilis, toxoplasmosis, toxocariasis, and human T-cell lymphotropic virus-1. Blood and intraocular fluid samples were examined. Patients with a diagnosis of brucellar uveitis were selected as cases and patients with a diagnosis of uveitis of other etiology were included as controls. The Goldmann-Witmer coefficient was determined. RESULTS: Twelve patients with clinical and laboratory findings suggestive of brucellar uveitis were considered as cases. Seven patients with uveitis of other etiology were selected as controls. Four (33.3%) patients with ocular brucellosis had negative ocular agglutinations and eight (66.7%) had positive agglutinations. No control cases had positive agglutinations for Brucella melitensis. The sensitivity of the test was 66.7% and the specificity 100%. Only one patient had a positive culture for B. melitensis in subretinal fluid. The Goldmann-Witmer coefficient was calculated in six cases of brucellosis uveitis and five uveitis controls. It was highly positive in three patients with ocular brucellosis. Tissue samples showed lymphoplasmacytic infiltrates. CONCLUSIONS: Intraocular serological tests could be used to support the diagnosis of ocular brucellosis.


Assuntos
Anticorpos Antibacterianos/sangue , Humor Aquoso , Brucella melitensis , Brucelose , Uveíte , Adolescente , Adulto , Testes de Aglutinação , Humor Aquoso/imunologia , Humor Aquoso/microbiologia , Biópsia , Brucella melitensis/imunologia , Brucella melitensis/isolamento & purificação , Brucelose/diagnóstico , Brucelose/imunologia , Brucelose/microbiologia , Feminino , Humanos , Imunoglobulina G/sangue , Masculino , Pessoa de Meia-Idade , Peru , Sensibilidade e Especificidade , Uveíte/diagnóstico , Uveíte/imunologia , Uveíte/microbiologia , Adulto Jovem
5.
Dermatol. peru ; 18(4): 354-358, oct.-dic. 2008. ilus, tab
Artigo em Espanhol | LILACS, LIPECS | ID: lil-537447

RESUMO

Presentamos el caso de una mujer de 32 años, procedente de Satipo, Junín, Selva Central del Perú, quien en mayo del 2006, luego del contacto con una oruga de mariposa, presenta severo compromiso sistémico hemorragíparo, con equimosis, hematomas, hematemesis, melenas y hematuria, y desarrollo de coagulopatía de consumo. El manejo fue de soporte con buena evolución y normalización de la coagulación al día doce. Es el primer caso de accidente probable por Lonomia sp con cuadro severo sistémico hemorrágico reportado en Perú.


We present the first case of Erucism by Lonomia spp. in Peru. A 32-year-old female patient was admitted with hematemesis, melena, hematuria and disseminated intravascular coagulation occurring after extensive skin contact with a caterpillar butterfly in Satipo, Junin. The patient was treated with supportive measures with complete recovery of the coagulopathy in twelve days.


Assuntos
Humanos , Adulto , Feminino , Coagulação Intravascular Disseminada , Dermatopatias , Hemorragia , Lepidópteros
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA